The Valley Hospital is a 451-bed, acute-care, not-for-profit hospital in Ridgewood, Bergen County, New Jersey. Valley staff includes more than 1,100 physicians, 3,700 employees and 3,000 volunteers. In 2020, Valley recorded 41,345 admissions, 51,792 emergency department visits and 3,528 births.

There are 451 beds in Valley Health System.

During the past decade, Valley Health System conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Valley Health System" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Meshalkin Research Institute of Pathology of Circulation" with 2 trials sponsored, "University of Rochester" with 2 trials sponsored, "Ipsen" with 1 trials sponsored and "Ottawa Heart Institute Research Corporation" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Valley Health System" #1 collaborator was "Biosense Webster, Inc." with 1 trials as a collaborator, "Medela AG" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "National Institutes of Health (NIH)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Valley Health System" are "Atrial Fibrillation" (3 trials), "Heart Failure" (3 trials), "Arterial Hypertension" (1 trials), "Breast Neoplasms" (1 trials) and "Cardiac Resynchronization Therapy" (1 trials). Many other conditions were trialed in "Valley Health System" in a lesser frequency.

Most popular intervention types in "Valley Health System" are "Procedure" (5 trials), "Drug" (4 trials), "Other" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib" (2 trials), "Circumferential PV isolation" (2 trials), "Active Suction (Dig)" (1 trials), "Active Suction (Trad)" (1 trials) and "Antiarrhythmic drug" (1 trials). Other intervention names were less common.

The vast majority of trials in "Valley Health System" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Valley Health System". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Valley Health System, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Valley Health System, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".